argenx announces results of Annual General Meeting of Shareholders
argenx SE - American Depositary Shares (ARGX)
US:NASDAQ Investor Relations:
investor.argenx.com/phoenix.zhtml?c=254223&p=irol-presentations
Company Research
Source: GlobeNewswire
May 7, 2024 – 5:30pm ET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of its Annual General Meeting of shareholders held today. All items on the agenda received a majority of votes in favor except for agenda item 5 (adoption of the remuneration policy). As part of the approved resolutions: The Company's annual report and annual accounts for the financial year ending December 31, 2023 were approved;Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the Board, supporting the Company’s innovation mission across therapeutic areas.Peter Verhaeghe and Dr. Pamela Klein have been re-appointed as non-executive directors to the Board of Directors for a term of 2 years;The Board of Direc
Show less
Read more
Impact Snapshot
Event Time:
ARGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARGX alerts
High impacting argenx SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ARGX
News
- argenx SE (NASDAQ: ARGX) had its price target lowered by analysts at JPMorgan Chase & Co. from $560.00 to $500.00. They now have an "overweight" rating on the stock.MarketBeat
- argenx SE (NASDAQ: ARGX) had its price target lowered by analysts at HC Wainwright from $451.00 to $448.00. They now have a "buy" rating on the stock.MarketBeat
- argenx SE (NASDAQ: ARGX) had its price target lowered by analysts at JMP Securities from $471.00 to $468.00. They now have a "market outperform" rating on the stock.MarketBeat
- argenx Reports First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
- argenx to Present at BofA Securities 2024 Health Care ConferenceGlobeNewswire
ARGX
Earnings
- 5/9/24 - Miss
ARGX
Sec Filings
- 5/9/24 - Form 6-K
- 5/8/24 - Form 6-K
- 4/16/24 - Form 6-K
- ARGX's page on the SEC website